However, it remains unclear from these studies whether the observed reduction in tumor growth with LEPR inhibition is due solely to effects on angiogenesis, as LEPRA2 also reduces Cyclin D expression in breast cancer cells in vitro (85). The gene discussed is LEPR; the disease is breast cancer.